The Epigenomics of Cancer

Akiyama, 2003, GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer, Mol. Cell. Biol., 23, 8429, 10.1128/MCB.23.23.8429-8439.2003 Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci. USA, 100, 3983, 10.1073/pnas.0530291100 Bakker, 2002, Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells, J. Biol. Chem., 277, 22573, 10.1074/jbc.M203009200 Baylin, 2006, Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?, Nat. Rev. Cancer, 6, 107, 10.1038/nrc1799 Belinsky, 1998, Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis, Proc. Natl. Acad. Sci. USA, 95, 11891, 10.1073/pnas.95.20.11891 Bernstein, 2006, A bivalent chromatin structure marks key developmental genes in embryonic stem cells, Cell, 125, 315, 10.1016/j.cell.2006.02.041 Bernstein, 2006, Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin, Mol. Cell. Biol., 26, 2560, 10.1128/MCB.26.7.2560-2569.2006 Bjerkvig, 2005, Opinion: the origin of the cancer stem cell: current controversies and new insights, Nat. Rev. Cancer, 5, 899, 10.1038/nrc1740 Bolden, 2006, Anticancer activities of histone deacetylase inhibitors, Nat. Rev. Drug Discov., 5, 769, 10.1038/nrd2133 Boyer, 2006, Polycomb complexes repress developmental regulators in murine embryonic stem cells, Nature, 441, 349, 10.1038/nature04733 Bracken, 2006, Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions, Genes Dev., 20, 1123, 10.1101/gad.381706 Bracken, 2003, EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer, EMBO J., 22, 5323, 10.1093/emboj/cdg542 Brueckner, 2005, Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases, Cancer Res., 65, 6305, 10.1158/0008-5472.CAN-04-2957 Cadieux, 2006, Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation, Cancer Res., 66, 8469, 10.1158/0008-5472.CAN-06-1547 Cameron, 1999, Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer, Nat. Genet., 21, 103, 10.1038/5047 Chai, 2005, Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells, Cancer Res., 65, 10192, 10.1158/0008-5472.CAN-05-1896 Chen, 2005, Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses, Cell, 123, 437, 10.1016/j.cell.2005.08.011 Cheng, 2004, Preferential response of cancer cells to zebularine, Cancer Cell, 6, 151, 10.1016/j.ccr.2004.06.023 Chuang, 2005, Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine, Mol. Cancer Ther., 4, 1515, 10.1158/1535-7163.MCT-05-0172 Constantinides, 1977, Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment, Nature, 267, 364, 10.1038/267364a0 Cornacchia, 1988, Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity, J. Immunol., 140, 2197, 10.4049/jimmunol.140.7.2197 Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322 Eckhardt, 2006, DNA methylation profiling of human chromosomes 6, 20 and 22, Nat. Genet., 38, 1378, 10.1038/ng1909 Esteller, 2000, Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer, Cancer Res., 60, 4366 Esteller, 2001, DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis, Hum. Mol. Genet., 10, 3001, 10.1093/hmg/10.26.3001 Fang, 2003, Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines, Cancer Res., 63, 7563 Feinberg, 2004, The history of cancer epigenetics, Nat. Rev. Cancer, 4, 143, 10.1038/nrc1279 Feinberg, 2006, The epigenetic progenitor origin of human cancer, Nat. Rev. Genet., 7, 21, 10.1038/nrg1748 Foster, 1998, Inactivation of p16 in human mammary epithelial cells by CpG island methylation, Mol. Cell. Biol., 18, 1793, 10.1128/MCB.18.4.1793 Fraga, 2005, Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer, Nat. Genet., 37, 391, 10.1038/ng1531 Frigola, 2006, Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band, Nat. Genet., 38, 540, 10.1038/ng1781 Futscher, 2002, Role for DNA methylation in the control of cell type specific maspin expression, Nat. Genet., 31, 175, 10.1038/ng886 Gao, 1998, Distinct functions are implicated for the GATA-4, -5, and -6 transcription factors in the regulation of intestine epithelial cell differentiation, Mol. Cell. Biol., 18, 2901, 10.1128/MCB.18.5.2901 Graff, 1995, E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas, Cancer Res., 55, 5195 Guarente, 2000, Sir2 links chromatin silencing, metabolism, and aging, Genes Dev., 14, 1021, 10.1101/gad.14.9.1021 Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Harikrishnan, 2005, Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing, Nat. Genet., 37, 254, 10.1038/ng1516 Janzen, 2006, Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a, Nature, 443, 421, 10.1038/nature05159 Jenuwein, 2006, The epigenetic magic of histone lysine methylation, FEBS J., 273, 3121, 10.1111/j.1742-4658.2006.05343.x Jones, 1980, Cellular differentiation, cytidine analogs and DNA methylation, Cell, 20, 85, 10.1016/0092-8674(80)90237-8 Jones, 1999, Cancer epigenetics comes of age, Nat. Genet., 21, 163, 10.1038/5947 Jones, 2002, The fundamental role of epigenetic events in cancer, Nat. Rev. Genet., 3, 415, 10.1038/nrg816 Jones, 1998, Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription, Nat. Genet., 19, 187, 10.1038/561 Karpf, 1999, Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells, Proc. Natl. Acad. Sci. USA, 96, 14007, 10.1073/pnas.96.24.14007 Kimura, 2002, Chromosomal gradient of histone acetylation established by Sas2p and Sir2p functions as a shield against gene silencing, Nat. Genet., 32, 370, 10.1038/ng993 Kinzler, 1996, Lessons from hereditary colorectal cancer, Cell, 87, 159, 10.1016/S0092-8674(00)81333-1 Kiyono, 1998, Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells, Nature, 396, 84, 10.1038/23962 Knoepfler, 2006, Myc influences global chromatin structure, EMBO J., 25, 2723, 10.1038/sj.emboj.7601152 Krishnamurthy, 2006, p16INK4a induces an age-dependent decline in islet regenerative potential, Nature, 443, 453, 10.1038/nature05092 Kuzmichev, 2005, Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation, Proc. Natl. Acad. Sci. USA, 102, 1859, 10.1073/pnas.0409875102 Laverriere, 1994, GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut, J. Biol. Chem., 269, 23177, 10.1016/S0021-9258(17)31636-8 Lee, 2006, Control of developmental regulators by Polycomb in human embryonic stem cells, Cell, 125, 301, 10.1016/j.cell.2006.02.043 Li, 2006, Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF, Nature, 442, 91, 10.1038/nature04802 Liang, 2002, Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine, Cancer Res., 62, 961 Lu, 2006, Inflammation, a key event in cancer development, Mol. Cancer Res., 4, 221, 10.1158/1541-7786.MCR-05-0261 Marks, 2001, Histone deacetylases and cancer: causes and therapies, Nat. Rev. Cancer, 1, 194, 10.1038/35106079 McDermott, 2006, p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells, PLoS Biol., 4, e51, 10.1371/journal.pbio.0040051 McGarvey, 2006, Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state, Cancer Res., 66, 3541, 10.1158/0008-5472.CAN-05-2481 Minucci, 2006, Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer, Nat. Rev. Cancer, 6, 38, 10.1038/nrc1779 Molkentin, 1997, Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis, Genes Dev., 11, 1061, 10.1101/gad.11.8.1061 Molofsky, 2006, Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing, Nature, 443, 448, 10.1038/nature05091 Nan, 1998, Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex, Nature, 393, 386, 10.1038/30764 Nelson, 2004, The role of inflammation in the pathogenesis of prostate cancer, J. Urol., 172, S6, 10.1097/01.ju.0000142058.99614.ff Orlando, 2003, Polycomb, epigenomes, and control of cell identity, Cell, 112, 599, 10.1016/S0092-8674(03)00157-0 Pirrotta, 2005, Epigenetic silencing mechanisms in budding yeast and fruit fly: different paths, same destinations, Mol. Cell, 18, 395, 10.1016/j.molcel.2005.04.013 Pruitt, 2006, Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation, PLoS Genet., 2, e40, 10.1371/journal.pgen.0020040 Reynolds, 2006, Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells, J. Biol. Chem., 281, 24790, 10.1074/jbc.M604175200 Riggs, 1983, 5-methylcytosine, gene regulation, and cancer, Adv. Cancer Res., 40, 1, 10.1016/S0065-230X(08)60678-8 Ringrose, 2004, Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins, Annu. Rev. Genet., 38, 413, 10.1146/annurev.genet.38.072902.091907 Roberts, 2004, The SWI/SNF complex–chromatin and cancer, Nat. Rev. Cancer, 4, 133, 10.1038/nrc1273 Saito, 2006, Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells, Cancer Cell, 9, 435, 10.1016/j.ccr.2006.04.020 Santi, 1983, On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs, Cell, 33, 9, 10.1016/0092-8674(83)90327-6 Schlesinger, 2007, Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer, Nat. Genet., 39, 232, 10.1038/ng1950 Seligson, 2005, Global histone modification patterns predict risk of prostate cancer recurrence, Nature, 435, 1262, 10.1038/nature03672 Sharpless, 2005, Cancer: crime and punishment, Nature, 436, 636, 10.1038/436636a Suka, 2002, Sir2p and Sas2p opposingly regulate acetylation of yeast histone H4 lysine16 and spreading of heterochromatin, Nat. Genet., 32, 378, 10.1038/ng1017 Suzuki, 2004, Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer, Nat. Genet., 36, 417, 10.1038/ng1330 Takai, 2002, Comprehensive analysis of CpG islands in human chromosomes 21 and 22, Proc. Natl. Acad. Sci. USA, 99, 3740, 10.1073/pnas.052410099 Tamaru, 2003, Synthesis of signals for de novo DNA methylation in Neurospora crassa, Mol. Cell. Biol., 23, 2379, 10.1128/MCB.23.7.2379-2394.2003 Toyota, 1999, CpG island methylator phenotype in colorectal cancer, Proc. Natl. Acad. Sci. USA, 96, 8681, 10.1073/pnas.96.15.8681 Valenta, 2006, HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies, EMBO J., 25, 2326, 10.1038/sj.emboj.7601147 Valk-Lingbeek, 2004, Stem cells and cancer; the polycomb connection, Cell, 118, 409, 10.1016/j.cell.2004.08.005 Varambally, 2002, The polycomb group protein EZH2 is involved in progression of prostate cancer, Nature, 419, 624, 10.1038/nature01075 Vire, 2006, The Polycomb group protein EZH2 directly controls DNA methylation, Nature, 439, 871, 10.1038/nature04431 Weisenberger, 2006, CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer, Nat. Genet., 38, 787, 10.1038/ng1834 Widschwendter, 2007, Epigenetic stem cell signature in cancer, Nat. Genet., 39, 157, 10.1038/ng1941 Wysocka, 2006, A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling, Nature, 442, 86, 10.1038/nature04815 Yamashita, 2002, Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma, Cancer Cell, 2, 485, 10.1016/S1535-6108(02)00215-5 Yamashita, 2003, Genetics supersedes epigenetics in colon cancer phenotype, Cancer Cell, 4, 121, 10.1016/S1535-6108(03)00190-9 Zhang, 1999, Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation, Genes Dev., 13, 1924, 10.1101/gad.13.15.1924